Trial Profile
A Single Center, Randomized, 2 Way Cross-Over, Phase 4 Study Comparing Usability of Zubsolv Sublingual Tablets 5.7/1.4 to Suboxone Sublingual Film 8/2 Including Ease of Use, Taste Preference, Dissolution Time, Desire to Abuse, and Overall Acceptance In Buprenorphine/Naloxone Treated Opioid Dependent Population
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Mar 2017
Price :
$35
*
At a glance
- Drugs Buprenorphine/naloxone (Primary)
- Indications Opioid-related disorders
- Focus Therapeutic Use
- Sponsors Reckitt Benckiser
- 31 Jan 2017 Status changed from active, no longer recruiting to completed.
- 25 Jan 2014 New trial record